Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07536152) titled 'Antihistamine for Prevention of HTR After Blood Primed CPB' on April 11.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Kasr El Aini Hospital
Condition:
Blood Transfusion Associated Adverse Reactions
Intervention:
Drug: Antihestamine
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: March 1, 2026
Target Sample Size: 40
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.go...